Precision Transcriptome Editing DOI
Xingyu Chen, Lei S. Qi

ACS Synthetic Biology, Год журнала: 2024, Номер 13(11), С. 3487 - 3496

Опубликована: Окт. 22, 2024

Manipulating RNA species in mammalian cells has emerged as an important strategy for precise gene expression control. Here we review recent advances precision transcriptome editing with a focus on tools that engineer specific transcripts abundance, translation, base editing, alternative isoforms, and chemical modifications. While some of these methods have demonstrated efficiency therapeutically relevant cellular or vivo models, most require further study their clinical safety efficacy. Precision engineering holds great potential both mechanistic biology future cell-based therapeutic applications.

Язык: Английский

CRISPR technologies for genome, epigenome and transcriptome editing DOI
Lukas Villiger,

Julia Joung,

Luke W. Koblan

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2024, Номер 25(6), С. 464 - 487

Опубликована: Фев. 2, 2024

Язык: Английский

Процитировано

77

Methylation across the central dogma in health and diseases: new therapeutic strategies DOI Creative Commons
Ruochen Liu, Erhu Zhao,

Huijuan Yu

и другие.

Signal Transduction and Targeted Therapy, Год журнала: 2023, Номер 8(1)

Опубликована: Авг. 24, 2023

The proper transfer of genetic information from DNA to RNA protein is essential for cell-fate control, development, and health. Methylation DNA, RNAs, histones, non-histone proteins a reversible post-synthesis modification that finetunes gene expression function in diverse physiological processes. Aberrant methylation caused by mutations or environmental stimuli promotes various diseases accelerates aging, necessitating the development therapies correct disease-driver imbalance. In this Review, we summarize operating system across central dogma, which includes writers, erasers, readers, reader-independent outputs. We then discuss how dysregulation contributes neurological disorders, cancer, aging. Current small-molecule compounds target modifiers show modest success certain cancers. methylome-wide action lack specificity lead undesirable biological effects cytotoxicity, limiting their therapeutic application, especially with monogenic cause different directions changes. Emerging tools capable site-specific manipulation hold great promise solve dilemma. With refinement delivery vehicles, these new are well positioned advance basic research clinical translation field.

Язык: Английский

Процитировано

59

Structures, mechanisms and applications of RNA-centric CRISPR–Cas13 DOI
Hui Yang, Dinshaw J. Patel

Nature Chemical Biology, Год журнала: 2024, Номер 20(6), С. 673 - 688

Опубликована: Май 3, 2024

Язык: Английский

Процитировано

34

Functional Impacts of Epitranscriptomic m6A Modification on HIV-1 Infection DOI Creative Commons
Stacia Phillips, Tarun Mishra, Siyu Huang

и другие.

Viruses, Год журнала: 2024, Номер 16(1), С. 127 - 127

Опубликована: Янв. 16, 2024

Epitranscriptomic RNA modifications play a crucial role in the posttranscriptional regulation of gene expression. N6-methyladenosine (m6A) is most prevalent internal modification eukaryotic and plays pivotal fate. m6A regulated by group cellular proteins, methyltransferases (writers) demethylases (erasers), which add remove methyl from adenosine, respectively. recognized RNA-binding proteins (readers) that specifically bind to m6A-modified RNA, mediating effects on stability, splicing, transport, translation. The functional significance viral an active area virology research. In this review, we summarize analyze current literature HIV-1 multifaceted functions regulating replication, evading innate immune responses infection. Furthermore, briefly discuss future directions therapeutic implications mechanistic studies epitranscriptomic modifications.

Язык: Английский

Процитировано

13

Ghost authors revealed: The structure and function of human N6‐methyladenosine RNA methyltransferases DOI Creative Commons
Kurtis Breger, Charlotte N. Kunkler, Nathan J. O'Leary

и другие.

Wiley Interdisciplinary Reviews - RNA, Год журнала: 2023, Номер 15(1)

Опубликована: Сен. 6, 2023

Abstract Despite the discovery of modified nucleic acids nearly 75 years ago, their biological functions are still being elucidated. N 6 ‐methyladenosine (m A) is most abundant modification in eukaryotic messenger RNA (mRNA) and has also been detected non‐coding RNAs, including long RNA, ribosomal small nuclear RNA. In general, m A marks can alter secondary structure initiate unique RNA–protein interactions that splicing, mRNA turnover, translation, just to name a few. Although human RNAs have known exist since 1974, structures methyltransferases responsible for writing established only recently. Thus far, there four confirmed catalyze transfer methyl group from S ‐adenosylmethionine (SAM) position adenosine, producing A: methyltransferase‐like protein (METTL) 3/METTL14 complex, METTL16, METTL5, zinc‐finger CCHC‐domain‐containing 4. Though targets, all contain Rossmann fold with conserved SAM‐binding pocket, suggesting they utilize similar catalytic mechanism transfer. For each methyltransferases, we present links disease, kinetic mechanisms, macromolecular structures. We discuss viruses parasites, assigning transcriptome specific molecules targeting enzymes hypermodified humans. Understanding critical steppingstone toward establishing epitranscriptome more broadly RNome. This article categorized under: Interactions Proteins Other Molecules > Protein‐RNA Recognition RNA‐Protein Complexes Interactions: Functional Implications

Язык: Английский

Процитировано

10

Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system DOI Creative Commons
Linli Wang, Hongbing Han

Heliyon, Год журнала: 2024, Номер 10(19), С. e38588 - e38588

Опубликована: Сен. 27, 2024

Язык: Английский

Процитировано

3

The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches DOI Open Access

Simon Deacon,

Lauryn Walker,

Masar Radhi

и другие.

Cancers, Год журнала: 2023, Номер 15(13), С. 3307 - 3307

Опубликована: Июнь 23, 2023

Glioblastoma is the most prevalent primary brain tumour and invariably confers a poor prognosis. The immense intra-tumoral heterogeneity of glioblastoma its ability to rapidly develop treatment resistance are key barriers successful therapy. As such, there an urgent need for greater understanding biology in order guide development novel therapeutics this field. N6-methyladenosine (m6A) abundant RNA modifications eukaryotes. Studies have demonstrated that regulation modification altered may serve regulate diverse mechanisms including glioma stem-cell self-renewal, tumorigenesis, invasion evasion. However, precise by which m6A exert their functional effects poorly understood. This review summarises evidence disordered discusses downstream on fate. wide-ranging biological consequences raises hope cancer therapies can be targeted against mechanism.

Язык: Английский

Процитировано

5

mRNA m6A detection DOI
Sharon Moshitch-Moshkovitz,

Michal Sevilla-Sharon,

Reut Ashwal-Fluss

и другие.

Nature Reviews Methods Primers, Год журнала: 2024, Номер 4(1)

Опубликована: Дек. 12, 2024

Язык: Английский

Процитировано

1

Regulation of non-coding RNAs DOI
Simona Panni,

Alessia Corbelli,

Joanna Sztuba-Solińska

и другие.

Elsevier eBooks, Год журнала: 2023, Номер unknown, С. 209 - 271

Опубликована: Янв. 1, 2023

Язык: Английский

Процитировано

3

Role of m6A RNA methylation in dosage compensation DOI Creative Commons
Hemant Chandru Naik,

Runumi Baro,

Amritesh Sarkar

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Апрель 22, 2024

Abstract In therian mammals, inactivation of one the X-chromosomes in female cells (XX) balances dosage X-linked gene expression between sexes, resulting monoallelic genes females similar to males (XY). Therefore, it creates a imbalance for with respect biallelically expressing autosomal (AA). X-to-autosome compensation is thought be achieved by transcriptional upregulation many from active X-chromosome both sexes. Here, we have delineated role m6A RNA methylation maintenance variety cell types, including embryonic, extra-embryonic and somatic cells. We show that marks tend less enriched on transcripts compared most studied types. However, our analysis demonstrates plays minor compensation. loss does not affect silencing inactive-X early embryonic lineages, suggesting dispensable inactivation. On contrary, depletion affects compensation, however, effect occurs lineage-specific manner. Taken together, study that, although are lowly ones, X-inactivation has contribution

Язык: Английский

Процитировано

0